findmyKOL

Scott Westphal, MD

Basic profile

University of Nebraska Medical Center

ORCIDNPI
RegionOmaha, NE · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Scott Westphal is a Nephrology physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 37 publications with 641 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex, matched via ORCID.

641citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

988102 Nebraska Medical Ctr
Omaha, NE 681988102

Telephone

402-559-4015

Registry record last updated 1 Jun 2015.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.3%
    Beta blocker17%
    Carvedilol69%Metoprolol Succinate15%Metoprolol Tartrate11%Propranolol Hcl5%
    Part D<11 patients
    Calcium channel blocker11.6%
    Nifedipine Er75%Amlodipine Besylate25%
    Part D36 patients

    + 8 more classes in this area

  • Metabolism & gastrointestinal

    35.5%
    Corticosteroid21.8%
    Prednisone100%
    Part D96 patients
    Proton pump inhibitor8.7%
    Pantoprazole Sodium57%Omeprazole33%Dexlansoprazole Dr10%
    Part D<11 patients

    + 2 more classes in this area

  • Hormonal (systemic)

    3.9%
    Calcium-sensing Receptor Agonist2.7%
    Cinacalcet Hcl100%
    Part D11 patients
    Mineralocorticoids1.2%
    Fludrocortisone Acetate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”